Colorado § 25-1.5-107 Pandemic influenza - purchase of antiviral therapy - definitions

Colorado Statutes

§ 25-1.5-107 — Pandemic influenza - purchase of antiviral therapy - definitions

Colorado § 25-1.5-107

Title 25Public

Art.Powers and Duties of the Department

This text of Colorado § 25-1.5-107 (Pandemic influenza - purchase of antiviral therapy - definitions) is published on Counsel Stack Legal Research, covering Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Colo. Rev. Stat. § 25-1.5-107 (2026).

Text

(1)The department may enter into partnerships with one or more authorized purchasers to purchase antiviral therapy in order to acquire a ready supply or stockpile of antiviral drugs in the event of an epidemic emergency, including pandemic influenza. If an entity wishes to purchase antiviral therapy through the department, the entity shall notify the department of its intent and shall demonstrate to the department, in a form and manner determined by the department, that the entity satisfies the criteria of an authorized purchaser. Upon a determination that an entity is an authorized purchaser, the department shall seek approval from the United States department of health and human services for the purchase of antiviral therapy by the authorized purchaser. Any purchase of antivira

Free access — add to your briefcase to read the full text and ask questions with AI

(1) The department may enter into partnerships with one or more authorized
purchasers to purchase antiviral therapy in order to acquire a ready supply or
stockpile of antiviral drugs in the event of an epidemic emergency, including
pandemic influenza. If an entity wishes to purchase antiviral therapy through the
department, the entity shall notify the department of its intent and shall
demonstrate to the department, in a form and manner determined by the
department, that the entity satisfies the criteria of an authorized purchaser. Upon a
determination that an entity is an authorized purchaser, the department shall seek
approval from the United States department of health and human services for the
purchase of antiviral therapy by the authorized purchaser. Any purchase of antiviral
therapy shall be approved by the United States department of health and human
services, and antiviral therapy shall be stored and used in accordance with state
and federal requirements.

(2) As used in this section, unless the context otherwise requires:

(a) Authorized purchaser means an entity licensed by the department
pursuant to section 25-1.5-103 (1)(a), a local public health agency, or a health
maintenance organization, as defined in section 10-16-102 (35), C.R.S., authorized to
operate in this state pursuant to part 4 of article 16 of title 10, C.R.S., that:

(I) Is part of the state pandemic preparedness and response plan;

(II) Will purchase antiviral therapy with its own funds; and

(III) Agrees to stockpile the antiviral therapy for use in an epidemic
emergency declared a disaster emergency pursuant to section 24-33.5-704, C.R.S.,
and to use the antiviral therapy only in accordance with state and federal
requirements and for no other purpose.

(b) Bioterrorism means the intentional use of microorganisms or toxins of
biological origin to cause death or disease among humans or animals.

(c) Emergency epidemic means cases of an illness or condition,
communicable or noncommunicable, caused by bioterrorism, pandemic influenza, or
novel and highly fatal infectious agents or biological toxins.

(d) Pandemic influenza means a widespread epidemic of influenza caused
by a highly virulent strain of the influenza virus.

Legislative History

Source: L. 2007: Entire section added with relocations, p. 1290, � 2, effective May 25. L. 2013: IP(2)(a) amended, (HB 13-1266), ch. 217, p. 992, � 61, effective May 13; (2)(a)(III) amended, (HB 13-1300), ch. 316, p. 1688, � 74, effective August 7.